These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11025462)

  • 1. The influence of enhanced postoperative inflammation by the intrapleural administration of streptococcal preparation (OK-432) on the prognosis of completely resected non-small-cell lung cancer.
    Uehara T; Yano T; Kuninaka S; Yoshino I; Asoh H; Ichinose Y
    J Surg Oncol; 2000 Sep; 75(1):51-4. PubMed ID: 11025462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial.
    Luh KT; Yang PC; Kuo SH; Chang DB; Yu CJ; Lee LN
    Cancer; 1992 Feb; 69(3):674-9. PubMed ID: 1309678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
    Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
    Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer.
    Sakamoto J; Teramukai S; Watanabe Y; Hayata Y; Okayasu T; Nakazato H; Ohashi Y;
    J Immunother; 2001; 24(3):250-6. PubMed ID: 11394503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection.
    Lee YC; Luh SP; Wu RM; Lee CJ
    Cancer Immunol Immunother; 1994 Oct; 39(4):269-74. PubMed ID: 7954529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalation therapy using a streptococcal preparation (OK-432) against bronchioloalveolar carcinoma of the lung.
    Yano T; Ichinose Y; Yokoyama H; Fukuyama Y; Sugio K; Sugimachi K
    Anticancer Res; 1999; 19(6C):5511-4. PubMed ID: 10697608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathoracic administration of OK-432 elevates the serum procalcitonin levels.
    Ogasawara T; Umezawa H; Kato S; Yano T; Kasamatsu N; Hashizume I
    Intern Med; 2012; 51(19):2727-31. PubMed ID: 23037463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A syndrome of inappropriate secretion of antidiuretic hormone associated with pleuritis caused by OK-432.
    Hanagiri T; Muranaka H; Hashimoto M; Nagashima A
    Respiration; 1998; 65(4):310-2. PubMed ID: 9730800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating carcinomatous pleural effusion by intrapleural injection of OK-432 in patients with non-small-cell lung cancer.
    Chao TY; Hwang WS
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Oct; 52(4):229-34. PubMed ID: 8258114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
    Kasahara K; Shibata K; Shintani H; Iwasa K; Sone T; Kimura H; Nobata K; Hirose T; Yoshimi Y; Katayama N; Ishiura Y; Kita T; Nishi K; Nakatsumi Y; Ryoma Y; Fujimura M; Nakao S
    Anticancer Res; 2006; 26(2B):1495-9. PubMed ID: 16619563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OK-432 pleurodesis for the treatment of pneumothorax in patients with interstitial pneumonia.
    Ogawa K; Takahashi Y; Murase K; Hanada S; Uruga H; Takaya H; Miyamoto A; Morokawa N; Kurosaki A; Kishi K
    Respir Investig; 2018 Sep; 56(5):410-417. PubMed ID: 29903606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of serum procalcitonin in patients after chemical pleurodesis with intrapleural injection of OK-432.
    Xu BL; Yu JQ; Tang KJ; Liu DY; Kuang YK
    Clin Respir J; 2014 Jan; 8(1):41-4. PubMed ID: 23711195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
    Kan N
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adhesion therapy for malignant pleural effusion (intrapleural administration of OK-432 with minocycline)].
    Tanaka A; Sato T
    Nihon Kokyuki Gakkai Zasshi; 1999 Jul; 37(7):531-7. PubMed ID: 10481458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of molluscum contagiosum in the immunosuppressed adult with topical injection of streptococcal preparation OK-432.
    Inui S; Asada H; Yoshikawa K
    J Dermatol; 1996 Sep; 23(9):628-30. PubMed ID: 8916664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients.
    Gochi A; Orita K; Fuchimoto S; Tanaka N; Ogawa N
    Br J Cancer; 2001 Feb; 84(4):443-51. PubMed ID: 11207036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral injection of a streptococcal preparation, OK-432, before surgery for gastric cancer. A randomized trial. Cooperative Study Group of Preoperative Intratumoral Immunotherapy for Cancer.
    Tanaka N; Gouchi A; Ohara T; Mannami T; Konaga E; Fuchimoto S; Okamura S; Sato K; Orita K
    Cancer; 1994 Dec; 74(12):3097-103. PubMed ID: 7982173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
    Fukushima M; Tsushima T; Ito H; Fukuda Y; Maruyama A; Fujita H; Yagihashi N; Tsuge T; Ishioka T; Kudo T; Kishibe S; Sato T; Machida S; Kogawa R; Takashima K; Koie H; Fujita K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracavitary administration of OK-432 with subcutaneous priming for malignant ascites in a case of advanced renal cell carcinoma.
    Kageyama Y; Sakai Y; Arai G; Hyochi N; Suzuki M; Masuda H; Kawakami S; Hayashi T; Okuno T; Kobayashi T; Kihara K
    Int J Urol; 2002 Jan; 9(1):57-9. PubMed ID: 11972652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.